Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

Why Argent BioPharma (ASX:RGT) is relying on a CannEpil licence and convertible funding as cash sits below one quarter of outflows

Argent BioPharma (ASX:RGT) is a cannabinoid-focused drug developer whose latest filings turn on a single question: can licensing deals and partner funding replace convertible-noteDebtbefore its cash is exhausted? TheAnnual Reportfor the year to 30 June 2026, authorised on 31 August 2026, shows a smaller …

Sonal Goyal | 16 October 2026

Why Visionflex Group (ASX:VFX) is leaning on subscription revenue and NSW Health hardware orders after a smaller FY26 loss

Visionflex Group (ASX:VFX) sells hardware and software for remote clinical examinations, and its FY26 results, released on 28 August 2026, show aBusinessattempting to move from one-off hardware sales towards recurring subscription revenue. The statutory loss fell sharply, but part of the improvement came from …

Sonal Goyal | 16 October 2026

Why Albright Metals (ASX:ABR) is selling Western Australian tenements to fund a gold and antimony push in New Brunswick

Albright Metals (ASX:ABR), formerly Bryah Resources, has spent 2026 selling Western Australian tenements to fund gold and antimony exploration in New Brunswick, Canada. In effect, the company is trading non-coreAssetsfor exposure to a single Canadian project while working with a short cash runway.

Sonal Goyal | 16 October 2026

Why Australian Critical Minerals (ASX:ACM) is judged on Flint gold-silver drilling in Peru rather than its critical-minerals label

Australian Critical Minerals (ASX:ACM) is a Western Australian-based explorer whose most visible activity in 2026 has been a maiden drilling program at the Flint gold-silver project in Peru. Despite the company's name, its recent news has centred on gold and silver rather than critical …

Sonal Goyal | 16 October 2026

Why Ausmon Resources (ASX:AOA) is pursuing South Australian ionic clay rare earths on loan funding while tenement expiries loom

Ausmon Resources (ASX:AOA) is a Sydney-based explorer with gold, silver, copper and base metals interests in New South Wales, a rare earths programme in South Australia and a rare earths target in Queensland. Its newest focus, ionic clay rare earths in the Murray Basin, …

Sonal Goyal | 16 October 2026

Why Askari Metals (ASX:AS2) is funding Ethiopian gold and Namibian critical-minerals exploration through small share issues

Askari Metals (ASX:AS2) describes itself in recent ASX filings as an African exploration company focused on gold and critical minerals in Ethiopia and Namibia. The company has moved its portfolio away from its earlier Australian and lithium projects, and its recent filings show it …

Sonal Goyal | 16 October 2026

Why Altitude Minerals (ASX:ATT) is heading into Nevada silver-gold drilling with about one quarter of funding on its own estimate

Altitude Minerals (ASX:ATT) is a multi-project explorer facing a question of timing. It has completed drilling in New South Wales and has drilling planned in Nevada, but its June 2026 quarterly report, dated 14 July 2026, put its funding at roughly 0.9 of a …

Sonal Goyal | 16 October 2026

Why Avira Resources (ASX:AVW) is resuming Mt Cattlin gold drilling ahead of a targeted maiden resource estimate

Avira Resources (ASX:AVW) is a Perth-based explorer whose focus has shifted to the Mt Cattlin gold project near Ravensthorpe in Western Australia. Wet weather suspended drilling during winter, and on 22 September 2026 the company said its contractor was mobilising to resume, with a …

Sonal Goyal | 16 October 2026

Why Australia United Mining (ASX:AYM) is juggling a Forsayth joint venture dispute and a nearly exhausted cash balance

Australia United Mining (ASX:AYM) is a small gold and base-metals explorer and part-time miner whose operations, a contractual dispute and its funding are closely linked. In late July 2026 the company disclosed a dispute with its Queensland joint venture partner, Forsayth Resources Pty Ltd, …

Sonal Goyal | 16 October 2026

What Does the Full US Release of CAP24 Mean for Saluda Medical (ASX:SLD) and Its Evoke System?

CAP24 is now being made broadly available to neurosurgery and orthopaedic spine practices across the United States, after a limited market release in selected centres. The company says physicians gave positive feedback during that limited release on the device's performance and its integration into …

Sonal Goyal | 16 October 2026
Support

Hi! How can we help you today?

Loading…